Diffuse large B-cell lymphoma trials in Serbia

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  Where

  Belgrade, Kamenitz, Kragujevac, Zemun

  Age

  18 years and over

  People

  102 worldwide

  Run by

  ImmunoVaccine Technologies, Inc. (IMV Inc.)

  See details and how to joinNCT04920617